Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $226M | — | $877M | $1.06B | $632M | $735M | $799M | $362M |
| Revenue growth | — | — | — | 21.1% | -40.5% | 16.3% | 8.7% | -54.7% |
| Operating income | $28.8M | — | -$64.5M | -$489M | -$319M | -$81.7M | -$7.05M | -$413M |
| Operating margin | 12.7% | — | -7.4% | -46.1% | -50.4% | -11.1% | -0.9% | -114.1% |
| Net income | $28.1M | — | -$44.3M | -$189M | -$149M | -$63.3M | -$2.93M | -$257M |
| Net margin | 12.4% | — | -5.0% | -17.8% | -23.5% | -8.6% | -0.4% | -71.1% |
| EPS (diluted) | — | — | -$3.35 | -$26.80 | -$17.72 | -$7.19 | -$0.66 | -$20.17 |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.44M | — | -$114M | -$299M | $60.9M | $109M | -$21.6M | -$122M |
| Capital expenditures | $6.17M | — | $14.5M | $19.8M | $13.5M | $13.7M | $13.7M | $8.25M |
| Free cash flow | -$727K | — | -$129M | -$319M | $47.4M | $95.4M | -$35.3M | -$130M |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $505K | $12.3M | $144M | $84.4M | $16.5M | $90.8M | $40.9M | $32.9M |
| Total assets | — | $1.60B | $2.11B | $2.07B | $1.66B | $1.50B | $1.49B | $987M |
| Long-term debt | — | $288M | $396M | $665M | $505M | $423M | $448M | $637M |
| Shareholders' equity | — | — | $380M | $353M | $269M | $231M | $242M | $37.9M |
| Retained earnings | — | — | -$18.8M | -$208M | -$357M | -$420M | -$423M | -$680M |
| Shares (wtd avg diluted) | — | — | 5.61M | 7.07M | 8.45M | 9.29M | 9.98M | 12.9M |
Every figure is extracted from GoHealth, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.